Non-viral vector-mediated uptake, distribution, and stability of chimeraplasts in human airway epithelial cells

David de Semir, Jordi Petriz, Anna Avinyó, Sara Larriba, Virginia Nunes, Teresa Casals, Xavier P. Estivill, Josep M. Aran

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Background: Chimeraplasty is a novel methodology that uses chimeric RNA/DNA oligonucleotides (chimeraplasts) to stimulate genomic DNA repair. Efficient uptake and nuclear localization of intact chimeraplasts are key parameters to achieve optimal correction of mutation defects into specific cell types. Methods: A 5′-end FITC-labeled 68-mer RNA/DNA oligonucleotide was complexed with the polycation polyethylenimine (PEI) and the cationic lipids Cytofectin and GenePorter. Flow cytometry was employed to evaluate chimeraplast uptake under different conditions. Intracellular chimeraplast distribution and co-localization with endocytosis markers were assessed by confocal microscopy. Relative quantification of chimeraplast metabolism was performed by denaturing PAGE and GeneScan™ analysis. Results: In airway epithelial cells, optimized chimeraplast uptake reached near 100% efficiency with the carriers tested. However, chimeraplast nuclear localization could only be achieved using PEI or Cytofectin. Chimeraplast/GenePorter lipoplexes were retained in the cytoplasm. PEI polyplexes and Cytofectin lipoplexes displayed different uptake rates and internalization mechanisms. Chimeraplast/PEI polyplexes were internalized at least partially by fluid-phase endocytosis. In contrast, phagocytosis may have contributed to the internalization process of large-sized chimeraplast/Cytofectin lipoplexes. Moreover, significant chimeraplast degradation was detected 24 h after transfection with both PEI polyplexes and Cytofectin lipoplexes, although the latter seemed to confer a higher degree of protection against nuclease degradation. Conclusion: Both Cytofectin and PEI are efficient for chimeraplast nuclear uptake into airway epithelial cells. However, despite the distinct structures and trafficking pathways of the corresponding complexes, none of them could prevent nuclease-mediated metabolism of the chimeric oligonucleotides. These findings should be taken into account for future investigations of chimeraplast-mediated gene repair in airway epithelial cells.

Original languageEnglish
Pages (from-to)308-322
Number of pages15
JournalJournal of Gene Medicine
Volume4
Issue number3
DOIs
Publication statusPublished - May 2002
Externally publishedYes

Fingerprint

Polyethyleneimine
Epithelial Cells
Oligonucleotides
Endocytosis
RNA
Fluorescein-5-isothiocyanate
DNA
Phagocytosis
Confocal Microscopy
DNA Repair
Transfection
cytofectin
Flow Cytometry
Cytoplasm
Lipids
Mutation
Genes

Keywords

  • Bronchial epithelial cells
  • Chimeraplast
  • Fluorescence analysis
  • Uptake

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Drug Discovery
  • Genetics(clinical)

Cite this

de Semir, D., Petriz, J., Avinyó, A., Larriba, S., Nunes, V., Casals, T., ... Aran, J. M. (2002). Non-viral vector-mediated uptake, distribution, and stability of chimeraplasts in human airway epithelial cells. Journal of Gene Medicine, 4(3), 308-322. https://doi.org/10.1002/jgm.264

Non-viral vector-mediated uptake, distribution, and stability of chimeraplasts in human airway epithelial cells. / de Semir, David; Petriz, Jordi; Avinyó, Anna; Larriba, Sara; Nunes, Virginia; Casals, Teresa; Estivill, Xavier P.; Aran, Josep M.

In: Journal of Gene Medicine, Vol. 4, No. 3, 05.2002, p. 308-322.

Research output: Contribution to journalArticle

de Semir, David ; Petriz, Jordi ; Avinyó, Anna ; Larriba, Sara ; Nunes, Virginia ; Casals, Teresa ; Estivill, Xavier P. ; Aran, Josep M. / Non-viral vector-mediated uptake, distribution, and stability of chimeraplasts in human airway epithelial cells. In: Journal of Gene Medicine. 2002 ; Vol. 4, No. 3. pp. 308-322.
@article{db90cb04d76e4b19998f3595bb3a3958,
title = "Non-viral vector-mediated uptake, distribution, and stability of chimeraplasts in human airway epithelial cells",
abstract = "Background: Chimeraplasty is a novel methodology that uses chimeric RNA/DNA oligonucleotides (chimeraplasts) to stimulate genomic DNA repair. Efficient uptake and nuclear localization of intact chimeraplasts are key parameters to achieve optimal correction of mutation defects into specific cell types. Methods: A 5′-end FITC-labeled 68-mer RNA/DNA oligonucleotide was complexed with the polycation polyethylenimine (PEI) and the cationic lipids Cytofectin and GenePorter. Flow cytometry was employed to evaluate chimeraplast uptake under different conditions. Intracellular chimeraplast distribution and co-localization with endocytosis markers were assessed by confocal microscopy. Relative quantification of chimeraplast metabolism was performed by denaturing PAGE and GeneScan™ analysis. Results: In airway epithelial cells, optimized chimeraplast uptake reached near 100{\%} efficiency with the carriers tested. However, chimeraplast nuclear localization could only be achieved using PEI or Cytofectin. Chimeraplast/GenePorter lipoplexes were retained in the cytoplasm. PEI polyplexes and Cytofectin lipoplexes displayed different uptake rates and internalization mechanisms. Chimeraplast/PEI polyplexes were internalized at least partially by fluid-phase endocytosis. In contrast, phagocytosis may have contributed to the internalization process of large-sized chimeraplast/Cytofectin lipoplexes. Moreover, significant chimeraplast degradation was detected 24 h after transfection with both PEI polyplexes and Cytofectin lipoplexes, although the latter seemed to confer a higher degree of protection against nuclease degradation. Conclusion: Both Cytofectin and PEI are efficient for chimeraplast nuclear uptake into airway epithelial cells. However, despite the distinct structures and trafficking pathways of the corresponding complexes, none of them could prevent nuclease-mediated metabolism of the chimeric oligonucleotides. These findings should be taken into account for future investigations of chimeraplast-mediated gene repair in airway epithelial cells.",
keywords = "Bronchial epithelial cells, Chimeraplast, Fluorescence analysis, Uptake",
author = "{de Semir}, David and Jordi Petriz and Anna Aviny{\'o} and Sara Larriba and Virginia Nunes and Teresa Casals and Estivill, {Xavier P.} and Aran, {Josep M.}",
year = "2002",
month = "5",
doi = "10.1002/jgm.264",
language = "English",
volume = "4",
pages = "308--322",
journal = "Journal of Gene Medicine",
issn = "1099-498X",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

TY - JOUR

T1 - Non-viral vector-mediated uptake, distribution, and stability of chimeraplasts in human airway epithelial cells

AU - de Semir, David

AU - Petriz, Jordi

AU - Avinyó, Anna

AU - Larriba, Sara

AU - Nunes, Virginia

AU - Casals, Teresa

AU - Estivill, Xavier P.

AU - Aran, Josep M.

PY - 2002/5

Y1 - 2002/5

N2 - Background: Chimeraplasty is a novel methodology that uses chimeric RNA/DNA oligonucleotides (chimeraplasts) to stimulate genomic DNA repair. Efficient uptake and nuclear localization of intact chimeraplasts are key parameters to achieve optimal correction of mutation defects into specific cell types. Methods: A 5′-end FITC-labeled 68-mer RNA/DNA oligonucleotide was complexed with the polycation polyethylenimine (PEI) and the cationic lipids Cytofectin and GenePorter. Flow cytometry was employed to evaluate chimeraplast uptake under different conditions. Intracellular chimeraplast distribution and co-localization with endocytosis markers were assessed by confocal microscopy. Relative quantification of chimeraplast metabolism was performed by denaturing PAGE and GeneScan™ analysis. Results: In airway epithelial cells, optimized chimeraplast uptake reached near 100% efficiency with the carriers tested. However, chimeraplast nuclear localization could only be achieved using PEI or Cytofectin. Chimeraplast/GenePorter lipoplexes were retained in the cytoplasm. PEI polyplexes and Cytofectin lipoplexes displayed different uptake rates and internalization mechanisms. Chimeraplast/PEI polyplexes were internalized at least partially by fluid-phase endocytosis. In contrast, phagocytosis may have contributed to the internalization process of large-sized chimeraplast/Cytofectin lipoplexes. Moreover, significant chimeraplast degradation was detected 24 h after transfection with both PEI polyplexes and Cytofectin lipoplexes, although the latter seemed to confer a higher degree of protection against nuclease degradation. Conclusion: Both Cytofectin and PEI are efficient for chimeraplast nuclear uptake into airway epithelial cells. However, despite the distinct structures and trafficking pathways of the corresponding complexes, none of them could prevent nuclease-mediated metabolism of the chimeric oligonucleotides. These findings should be taken into account for future investigations of chimeraplast-mediated gene repair in airway epithelial cells.

AB - Background: Chimeraplasty is a novel methodology that uses chimeric RNA/DNA oligonucleotides (chimeraplasts) to stimulate genomic DNA repair. Efficient uptake and nuclear localization of intact chimeraplasts are key parameters to achieve optimal correction of mutation defects into specific cell types. Methods: A 5′-end FITC-labeled 68-mer RNA/DNA oligonucleotide was complexed with the polycation polyethylenimine (PEI) and the cationic lipids Cytofectin and GenePorter. Flow cytometry was employed to evaluate chimeraplast uptake under different conditions. Intracellular chimeraplast distribution and co-localization with endocytosis markers were assessed by confocal microscopy. Relative quantification of chimeraplast metabolism was performed by denaturing PAGE and GeneScan™ analysis. Results: In airway epithelial cells, optimized chimeraplast uptake reached near 100% efficiency with the carriers tested. However, chimeraplast nuclear localization could only be achieved using PEI or Cytofectin. Chimeraplast/GenePorter lipoplexes were retained in the cytoplasm. PEI polyplexes and Cytofectin lipoplexes displayed different uptake rates and internalization mechanisms. Chimeraplast/PEI polyplexes were internalized at least partially by fluid-phase endocytosis. In contrast, phagocytosis may have contributed to the internalization process of large-sized chimeraplast/Cytofectin lipoplexes. Moreover, significant chimeraplast degradation was detected 24 h after transfection with both PEI polyplexes and Cytofectin lipoplexes, although the latter seemed to confer a higher degree of protection against nuclease degradation. Conclusion: Both Cytofectin and PEI are efficient for chimeraplast nuclear uptake into airway epithelial cells. However, despite the distinct structures and trafficking pathways of the corresponding complexes, none of them could prevent nuclease-mediated metabolism of the chimeric oligonucleotides. These findings should be taken into account for future investigations of chimeraplast-mediated gene repair in airway epithelial cells.

KW - Bronchial epithelial cells

KW - Chimeraplast

KW - Fluorescence analysis

KW - Uptake

UR - http://www.scopus.com/inward/record.url?scp=0036581926&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036581926&partnerID=8YFLogxK

U2 - 10.1002/jgm.264

DO - 10.1002/jgm.264

M3 - Article

C2 - 12112648

AN - SCOPUS:0036581926

VL - 4

SP - 308

EP - 322

JO - Journal of Gene Medicine

JF - Journal of Gene Medicine

SN - 1099-498X

IS - 3

ER -